GIUSEPPE CLAUDIO VISCOMI,FERDINANDO MANNELLO,CRISTIANA BRUNO
申请号：
PT13161007
公开号：
PT2609925T
申请日:
2011.04.20
申请国别(地区):
PT
年份:
2018
代理人:
摘要：
The present invention describes dematan sulfate obtained from sulodexide for use in the reduction of circulating matrix metalloproteinase (MMPs), in particular MMP-9. Dermatan sulfate is useful for the treatment of pathologies wherein the MMPs are involved, such as cardiovascular disease, cardiovascular disease caused by diabetes, varicose veins, chronic venous insufficiency (CVI), gastrointestinal ulcers, pulmonary disease, and neoplastic pathologies.
